BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 17519477)

  • 1. Prospective comparison of secretin-stimulated MRCP with manometry in the diagnosis of sphincter of Oddi dysfunction types II and III.
    Baillie J; Kimberly J
    Gut; 2007 Jun; 56(6):742-4. PubMed ID: 17519477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective comparison of secretin-stimulated magnetic resonance cholangiopancreatography with manometry in the diagnosis of sphincter of Oddi dysfunction types II and III.
    Pereira SP; Gillams A; Sgouros SN; Webster GJ; Hatfield AR
    Gut; 2007 Jun; 56(6):809-13. PubMed ID: 17005767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of secretin-stimulated magnetic resonance pancreatography and manometry results in patients with suspected sphincter of oddi dysfunction.
    Aisen AM; Sherman S; Jennings SG; Fogel EL; Li T; Cheng CL; Devereaux BM; McHenry L; Watkins JL; Lehman GA
    Acad Radiol; 2008 May; 15(5):601-9. PubMed ID: 18423317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic yield of ERCP and secretin-enhanced MRCP and EUS in patients with acute recurrent pancreatitis of unknown aetiology.
    Mariani A; Arcidiacono PG; Curioni S; Giussani A; Testoni PA
    Dig Liver Dis; 2009 Oct; 41(10):753-8. PubMed ID: 19278909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of morphine-neostigmine and secretin provocation on pancreaticobiliary morphology in healthy subjects: a randomized, double-blind crossover study using serial MRCP.
    Chowdhury AH; Humes DJ; Pritchard SE; Marciani L; Gowland PA; Simpson J; Lobo DN
    World J Surg; 2011 Sep; 35(9):2102-9. PubMed ID: 21656308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MRCP-secretin test-guided management of idiopathic recurrent pancreatitis: long-term outcomes.
    Testoni PA; Mariani A; Curioni S; Zanello A; Masci E
    Gastrointest Endosc; 2008 Jun; 67(7):1028-34. PubMed ID: 18179795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sphincter of Oddi dysfunction.
    Baillie J
    Curr Gastroenterol Rep; 2010 Apr; 12(2):130-4. PubMed ID: 20424985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of variable-stiffness guide wires on basal biliary sphincter of Oddi pressure measured at endoscopic retrograde cholangiopancreatography.
    Blaut U; Alazmi W; Sherman S; Fogel EL; Watkins JL; Bucksot L; Lehman GA
    Endoscopy; 2010 May; 42(5):375-80. PubMed ID: 20425665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency of sphincter of Oddi dysfunction in patients with previously normal sphincter of Oddi manometry studies.
    Khashab MA; Watkins JL; McHenry L; Lazzell-Pannell L; Schmidt S; Sherman S; Lehman GA; Fogel EL
    Endoscopy; 2010 May; 42(5):369-74. PubMed ID: 19967632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secretin-enhanced MR cholangiopancreatography: spectrum of findings.
    Tirkes T; Sandrasegaran K; Sanyal R; Sherman S; Schmidt CM; Cote GA; Akisik F
    Radiographics; 2013; 33(7):1889-906. PubMed ID: 24224585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endoscopic approach to the patient with motility disorders of the bile duct and sphincter of Oddi.
    Leung WD; Sherman S
    Gastrointest Endosc Clin N Am; 2013 Apr; 23(2):405-34. PubMed ID: 23540967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sphincter of Oddi manometry.
    Pfau PR; Banerjee S; Barth BA; Desilets DJ; Kaul V; Kethu SR; Pedrosa MC; Pleskow DK; Tokar J; Varadarajulu S; Wang A; Song LM; Rodriguez SA
    Gastrointest Endosc; 2011 Dec; 74(6):1175-80. PubMed ID: 22032848
    [No Abstract]   [Full Text] [Related]  

  • 13. Diagnosis and management of sphincter of Oddi dysfunction and pancreas divisum.
    Madura JA; Madura JA
    Surg Clin North Am; 2007 Dec; 87(6):1417-29, ix. PubMed ID: 18053839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solid state biliary manometry catheter: impact on diagnosis and post-study pancreatitis.
    Frenz MB; Wehrmann T
    Curr Gastroenterol Rep; 2007 Apr; 9(2):171-4. PubMed ID: 17418064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sphincter of Oddi dysfunction: overdue for an overhaul.
    Baillie J
    Am J Gastroenterol; 2005 Jun; 100(6):1217-20. PubMed ID: 15929746
    [No Abstract]   [Full Text] [Related]  

  • 16. Acinarization (parenchymal blush) observed during secretin-enhanced MRCP: clinical implications.
    Sandrasegaran K; Bodanapally U; Cote GA; Benzinger S; Patel AA; Akisik FM; Sherman S
    AJR Am J Roentgenol; 2014 Sep; 203(3):607-14. PubMed ID: 25148164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pancreatic sphincter of oddi dysfunction].
    Han J; Kim HG
    Korean J Gastroenterol; 2009 Jun; 53(6):333-5. PubMed ID: 19556838
    [No Abstract]   [Full Text] [Related]  

  • 18. Technology insight: applications of MRI for the evaluation of benign disease of the pancreas.
    Kinney TP; Punjabi G; Freeman M
    Nat Clin Pract Gastroenterol Hepatol; 2007 Mar; 4(3):148-59. PubMed ID: 17339852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sphincter of Oddi manometry: still a valid gold standard?
    Haber GB
    Endoscopy; 2010 May; 42(5):413-5. PubMed ID: 20425666
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of prior sphincterotomy on the secretin-stimulated magnetic resonance cholangiopancreatography (s-MRCP).
    Chopra A; Alkaade S; Balci NC; Burton F
    Acad Radiol; 2009 Nov; 16(11):1381-5. PubMed ID: 19683944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.